| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| tg-1801 | b-lymphocyte surface antigen b4 | NA | Successful target | TTD | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] B-Cell Lymphomas[MeSHID:D016393] |
NA | phase 1 | unknown |
| tg-1801 | leukocyte surface antigen cd47 | NA | Clinical trial target | TTD | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] B-Cell Lymphomas[MeSHID:D016393] |
NA | phase 1 | unknown |
| click here to return to the previous page | ||||||||